Introduction Placental transverse relaxation time (T2) assessed by MRI may have the
potential to improve the antenatal identification of small for gestational age. The aims of this …

Objective In attempt to shed new light on the etiopathogenesis of fetal growth restriction
(FGR) we aimed to compare pregnancy outcomes and placental histopathology in cases of …

OBJECTIVES: Intrauterine growth restriction (IUGR) is a diagnostic challenge, since
ultrasound fetal biometry (UFB) provides only a 50% detection rate for IUGR. This may be …

Background Fetal growth restriction (FGR) is a condition that affects 5–10% of pregnancies
and is the second most common cause of perinatal mortality. This review presents the most …

Abstract Objective Placental growth factor (PlGF) has shown promise in identification of
placental fetal growth restriction (FGR). We aimed to investigate the association between …

Placental growth factor (PlGF) and vascular endothelial growth factor (VEGF) are involved in
placental angiogenesis through interactions with the VEGFR‐1 and VEGFR‐2 receptors …

Purpose To compare the placental pathologies and perinatal outcomes in fetal growth
restriction (FGR) pregnancies with and without oligohydramnios. Methods A retrospective …

Background: T2* relaxometry has been identified as a non-invasive way to study the
placenta in-vivo with good potential to identify placental insufficiency. Typical interpretation …

Purpose The purpose of this study was to estimate fetal O2 delivery rate in vivo across a
range of gestational ages. Toward this, a calibration equation for T2‐based oximetry was …

OBJECTIVES: One of the causes of intrauterine fetal growth restriction (FGR) can be
pathology of the placenta. The aim of this study was to compare macroscopic and …